fate therapeutics stock price target
Analyst Recommendations on FATE THERAPEUTICS INC. 69 rows FATE Stock Trend.
Analyst Recommendations on FATE THERAPEUTICS INC.
. View real-time FATE stock price and news along with industry-best analysis. Wedbush Adjusts Fate Therapeutics Price Target to 77 From 74 Keeps Outperform Ratin. Nasdaq AT CLOSE 400 PM EDT 031622.
Fate Therapeutics Inc FATE stock is trading at 3859 as of 940 AM on Friday Feb 11 an increase of 047 or 125 from the previous closing price of 3811. The minimum target price for Fate Therapeutics analysts is 9489. Evolution of the average Target Price on FATE THERAPEUTICS INC.
Related
Average price target from 19 ratings. Learn About Diversifying Your Investments. Complete Fate Therapeutics Inc.
FATE has a higher upside potential average analyst target price relative to current price than 100215 of stocks in the mid market cap category. HC Wainwright Adjusts Fate Therapeutics Price Target to 115 from 122 Keeps Buy Rati. AFTER HOURS 707 PM EDT 031622.
7 2020 at 718 am. Target values for the price of one Fate Therapeutics share for Oct 2025. The company has an average price target of 9325 with a high of 12200 and a low of 6200.
Last 18 months Recommendations Chart FATE THERAPEUTICS INC. Morgan Stanley lowered their price target on shares of Fate Therapeutics from 7400 to 6200 and set an equal weight rating for the company in a research report on Wednesday December 15th. ET by Tomi Kilgore Fate Therapeutics stock price target raised to 65 from 40 at Truist.
Volume today is below average. Fate Therapeutics stock price target raised to 88 from 55 at Wedbush Dec. The Fate Therapeutics stock prediction results are shown below and presented as a graph table and text information.
5 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 9360 with the highest FATE stock price forecast at 11500 and the lowest FATE stock price forecast at 7400. Stocks similar to Fate Therapeutics Inc in the Pharmaceutical. The firm presently has a buy rating on the biopharmaceutical companys stock.
Stock quotes are provided by Factset Morningstar and SP Capital IQ. Fate Therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. 5 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 9360 with the highest FATE stock price forecast at 11500 and the.
The stock lies in the middle of a very wide and. Below is a summary of how these 4 analysts rated Fate Therapeutics over the. Find Out Which Investments Align with Your Financial Goals.
The stock has traded between 3832 and 3995 so far today. The weighted average target price per Fate Therapeutics share in Oct 2025 is. Fate Therapeutics Inc quote is equal to 31290 USD at 2022.
Stock information by Barrons. Fate Therapeutics NASDAQFATE Get Rating had its target price cut by analysts at HC Wainwright from 12200 to 11500 in a research note issued to investors on Friday Benzinga reports. Over the past 96 months FATEs priceearnings ratio has gone down 256.
Over the past 96 months FATEs pricesales ratio has gone. Fate Therapeutics FATE stock price prediction is 91263033384911 USD. 1y Target Est 9453 Fair Value is the appropriate price for the shares of a company based on its earnings and growth rate also interpreted as when PE Ratio Growth Rate.
In Oct the positive dynamics for Momo shares will prevail with possible monthly volatility of. According to analysts consensus price target of 9500 Fate Therapeutics has a forecasted upside of 1383 from its current price of 3986. In terms of how Fate Therapeutics Inc fares relative to Pharmaceutical Products stocks note that its average analyst price target is greater than 94038 of that group.
Ad The Investing Experience Youve Been Waiting for. Ad Financial Security is Attainable. In comparison to the median Healthcare stock FATEs pricesales ratio is 11793 higher now standing at 1452.
Amount of Analyst Coverage Fate Therapeutics has only been the subject of 2 research reports in the past 90 days. Target Price consensus revisions. 130 rows The average price target is 10413 with a high forecast of 14500 and a low.
Morgan Stanley Adjusts Fate Therapeutics Price Target to 52 From 62 Maintains Equalw.
Could Fate Therapeutics Be A Millionaire Maker Stock The Motley Fool
Fate Therapeutics Share Price Usd0 001
3 Stocks Than Can Turn 10 000 Into 50 000 By 2025 The Motley Fool
Fate Therapeutics Enters Oversold Territory Fate Nasdaq
Fate Therapeutics Stock Falls On Trial Data For Lymphoma Treatment Thestreet
Fate Fate Therapeutics Inc Stock Overview U S Nasdaq Barron S
Pin By Techboomie Asmr On Stocks Ark Fund Development
6pv Gvpppp 7am
Fate Fate Therapeutics Inc Stock Overview U S Nasdaq Barron S
Fate Therapeutics Jumped On Supportive Trial Data Nasdaq Fate Seeking Alpha
Fate Stock Price And Chart Nasdaq Fate Tradingview
Fate Stock Price And Chart Nasdaq Fate Tradingview
What 4 Analyst Ratings Have To Say About Fate Therapeutics Markets Insider
Fate Stock Price And Chart Nasdaq Fate Tradingview
Fate Therapeutics Fate Stock Price News Info The Motley Fool
Fate Therapeutics Nasdaq Fate Stock Price News Charts Benzinga
Fate Stock Price And Chart Nasdaq Fate Tradingview
Fate Stock Price And Chart Nasdaq Fate Tradingview
Fate Therapeutics Fate Stock Price News Info The Motley Fool
